Inventor · disambiguated record
Lisa Scherer
Also filed as: SCHERER LISA
8 granted patents·7 pending applications·24 citations·filing 2011–2024
82Inventor score
Top patents by PatentIndex Score
15 records- 0190US11643659B2Conditional-siRNAS and uses thereof in treating acute myeloid leukemiaHOPE CITY·Filed 2020·Granted May 9, 2023·2 cites·16 claims
- 0288US9725715B2Signal activatable constructs and related components compositions methods and systemsCALIFORNIA INST OF TECHN·Filed 2015·Granted Aug 8, 2017·5 cites·21 claims
- 0386US9206419B2Targeting domain and related signal activated molecular deliveryCALIFORNIA INST OF TECHN·Filed 2013·Granted Dec 8, 2015·5 cites·23 claims
- 0485US9115355B2Exonuclease resistant polynucleotide and related duplex polynucleotides, constructs, compositions, methods and systemsCALIFORNIA INST OF TECHN·Filed 2013·Granted Aug 25, 2015·5 cites·26 claims
- 0585US8710199B2Signal activated molecular deliveryHAN SI-PING·Filed 2011·Granted Apr 29, 2014·6 cites·33 claims
- 0684US11999954B2Programmable conditional SIRNAS and uses thereofHOPE CITY·Filed 2021·Granted Jun 4, 2024·1 cites·11 claims
- 0775US2024401043A1Programmable conditional sirnas and uses thereofHOPE CITY·Filed 2024·Application pending·0 cites
- 0873US2023407308A1Conditional-sirnas and uses thereof in treating acute myeloid leukemiaHOPE CITY·Filed 2023·Application pending·0 cites
- 0961US2025188454A1Signal activatable nucleic acid constructs with wobble base pairingsSWITCH THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1061US2025188453A1Conditionally activatable nucleic acid complexesSWITCH THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1161US2025257353A1Signal activatable nucleic acid complexesSWITCH THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1249US12054711B2Meta-stable oligonucleotides junctions for delivery of therapeuticsHOPE CITY·Filed 2018·Granted Aug 6, 2024·0 cites·19 claims
- 1349US2016130581A1Targeting domain and related signal activated molecular deliveryCALIFORNIA INST OF TECHN·Filed 2015·Application pending·0 cites
- 1441US12385041B2Conditional-siRNAS and uses thereof in treating cardiac hypertrophyHOPE CITY·Filed 2018·Granted Aug 12, 2025·0 cites·21 claims
- 1538US2016289681A1Rna-based hiv inhibitorsHOPE CITY·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →